GlassScriptPhysician profile
Pamela Daher
NPI 1588083984
$14,016.18
in general payments reported to CMS, 2019-2025
12 companies · $167 in 2025
The $167 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $499 · 2020: $3,172 · 2021: $4,502 · 2023: $4,527 · 2024: $1,148 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,035 · Travel and Lodging: $1,503 · Food and Beverage: $1,295 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,035.06 |
| Travel and Lodging | $1,503.11 |
| Food and Beverage | $1,295.21 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,414.10 | 2019-2024 | Davinci Xi, Da Vinci Surgical System |
| Thd America, INC. | $1,643.09 | 2023-2024 | |
| Stryker Corporation | $486.06 | 2019-2020 | |
| Baxter Healthcare | $121.12 | 2021 | |
| Hollister Incorporated | $114.87 | 2025 | New Image |
| Medtronic, INC. | $88.41 | 2024-2025 | Interstim |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Merck Sharp & Dohme LLC | $33.81 | 2019-2020 | |
| Boston Scientific Corporation | $30.37 | 2024 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Braintree Laboratories, INC. | $21.45 | 2023 | Sutab |
| Hemosonics LLC | $15.91 | 2021 | |
| Kerecis Limited | $11.93 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pamela Daher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.